Published
2025-03-30
Section
Review Articles
License
Copyright (c) 2025 Yasser Fakri Mustafa, Wejdan Al-Shakarchi
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The journal adopts the Attribution-NonCommercial 4.0 International (CC BY-NC 4.0), which means that anyone can reuse and redistribute the materials for non-commercial purposes as long as you follow the license terms and the original source is properly cited.
Author(s) shall retain the copyright of their work and grant the Journal/Publisher rights for the first publication with the work concurrently licensed since 2023 Vol.8 No.2.
Under this license, author(s) will allow third parties to download, reuse, reprint, modify, distribute and/or copy the content under the condition that the authors are given credit. No permission is required from the authors or the publisher.
This broad license intends to facilitate free access, as well as the unrestricted use of original works of all types. This ensures that the published work is freely and openly available in perpetuity.
By providing open access, the following benefits are brought about:
- Higher Visibility, Availability and Citations-free and unlimited accessibility of the publication over the internet without any restrictions increases citation of the article.
- Ease of search-publications are easily searchable in search engines and indexing databases.
- Rapid Publication – accepted papers are immediately published online.
- Available for free download immediately after publication at https://esp.as-pub.com/index.php/ESP
Copyright Statement
1.The authors certify that the submitted manuscripts are original works, do not infringe the rights of others, are free from academic misconduct and confidentiality issues, and that there are no disputes over the authorship scheme of the collaborative articles. In case of infringement, academic misconduct and confidentiality issues, as well as disputes over the authorship scheme, all responsibilities will be borne by the authors.
2. The author agrees to grant the Editorial Office of Environment and Social Psychology a licence to use the reproduction right, distribution right, information network dissemination right, performance right, translation right, and compilation right of the submitted manuscript, including the work as a whole, as well as the diagrams, tables, abstracts, and any other parts that can be extracted from the work and used in accordance with the characteristics of the journal. The Editorial Board of Environment and Social Psychology has the right to use and sub-licence the above mentioned works for wide dissemination in print, electronic and online versions, and, in accordance with the characteristics of the periodical, for the period of legal protection of the property right of the copyright in the work, and for the territorial scope of the work throughout the world.
3. The authors are entitled to the copyright of their works under the relevant laws of Singapore, provided that they do not exercise their rights in a manner prejudicial to the interests of the Journal.
About Licence
Environment and Social Psychology is an open access journal and all published work is available under the Creative Commons Licence, Authors shall retain copyright of their work and grant the journal/publisher the right of first publication, and their work shall be licensed under the Attribution-NonCommercial 4.0 International (CC BY-NC 4.0).
Under this licence, the author grants permission to third parties to download, reuse, reprint, modify, distribute and/or copy the content with attribution to the author. No permission from the author or publisher is required.
This broad licence is intended to facilitate free access to and unrestricted use of original works of all kinds. This ensures that published works remain free and accessible in perpetuity. Submitted manuscripts, once accepted, are immediately available to the public and permanently accessible free of charge on the journal’s official website (https://esp.as-pub.com/index.php/ESP). Allowing users to read, download, copy, print, search for or link to the full text of the article, or use it for other legal purposes. However, the use of the work must retain the author's signature, be limited to non-commercial purposes, and not be interpretative.
Click to download <Agreement on the Licence for the Use of Copyright on Environmental and Social Psychology>.
How to Cite
The psychotropic potential of coumarins: Mechanisms, efficacy, and future prospects
Yasser Fakri Mustafa
Department of Pharmaceutical Chemistry, College of Pharmacy, University of Mosul, Mosul, 41001, Iraq
Wejdan Al-Shakarchi
Department of Pharmaceutical Chemistry, College of Pharmacy, University of Mosul, Mosul, 41001, Iraq
DOI: https://doi.org/10.59429/esp.v10i3.3534
Keywords: coumarins; psychological disorders; neurotransmitter modulation; anxiolytic attribute; antidepressant effect; natural psychopharmacology
Abstract
Mental health disorders, including anxiety, depression, and cognitive impairments, have become increasingly prevalent in modern society, demanding innovative and effective treatment options. While conventional pharmacotherapy remains the cornerstone of psychiatric treatment, its limitations—ranging from side effects to resistance—have fueled the search for novel therapeutic agents. Coumarins, a group of naturally occurring phenolic compounds, have become excellent candidates for this search because they have many biological functions. This review looks at the possibility of coumarins as neuroactive compounds that can change important pathways that could link to mental disorders. Coumarins have powerful antidepressants, anxiety-relieving, and brain-boosting effects because they can change neurotransmitter systems, especially serotoninergic, dopaminergic, and GABAergic pathways. Their anti-inflammatory, antioxidant, and neuroprotective properties also make them potentially useful as medicines, since they can help with the underlying pathophysiology of mental health conditions. Beyond their pharmacodynamic properties, coumarins also present advantages in terms of bioavailability and safety, making them attractive candidates for future drug development. Despite promising preclinical and early clinical findings, the transition from laboratory to therapeutic application remains an unexplored area. Challenges such as dose optimization, formulation strategies, and clinical validation require further exploration. Finally, this review integrates phytochemistry, neuroscience, and psychopharmacology to discuss coumarins, a class of naturally occurring neurotherapeutics with limited research. As more research is done to find out what all coumarins can do, they may change the way psychiatric treatments are done by providing a natural, multi-target approach to mental health in a time when mental distress is on the rise.
References
[1]. 1.Bergman YS, Segel-Karpas D. Aging anxiety, loneliness, and depressive symptoms among middle-aged adults: The moderating role of ageism. Journal of Affective Disorders. 2021;290:89–92.
[2]. 2.Margoni M, Preziosa P, Rocca MA, Filippi M. Depressive symptoms, anxiety and cognitive impairment: emerging evidence in multiple sclerosis. Translational Psychiatry. 2023;13(1):264.
[3]. 3.Mrozek W, Socha J, Sidorowicz K, Skrok A, Syrytczyk A, Piątkowska-Chmiel I, Herbet M. Pathogenesis and treatment of depression: Role of diet in prevention and therapy. Nutrition. 2023;115:112143.
[4]. 4.Estrada-Camarena E, López-Rubalcava C, Vega-Rivera N, González-Trujano M. Antidepressant- and Anxiolytic-like Effects of Pomegranate: Is It Acting by Common or Well-Known Mechanisms of Action? Plants. 2024;13(16):2205.
[5]. 5.Leichsenring F, Fonagy P, Heim N, Kernberg OF, Leweke F, Luyten P, Salzer S, Spitzer C, Steinert C. Borderline personality disorder: a comprehensive review of diagnosis and clinical presentation, etiology, treatment, and current controversies. World Psychiatry. 2024;23(1):4–25.
[6]. 6.Finnerup NB, Kuner R, Jensen TS. Neuropathic Pain: From Mechanisms to Treatment. Physiological Reviews. 2021;101(1):259–301.
[7]. 7.Mulder R, Murray G, Rucklidge J. Common versus specific factors in psychotherapy: opening the black box. The lancet psychiatry. 2017;4(12):953–62.
[8]. 8.Krause M. Lessons from ten years of psychotherapy process research Lessons from ten years of psychotherapy process research. Psychotherapy research. 2024;34(3):261–75.
[9]. 9.Pylypenko N, Shevchenko N, Formaniuk Y, Herasina S, Horetska O, Kosianova O. Psychotherapeutic Counseling in Promoting Personal Development. BRAIN Broad Research in Artificial Intelligence and Neuroscience. 2022;13(3):119–37.
[10]. 10.Marx W, Penninx BWJH, Solmi M, Furukawa TA, Firth J, Carvalho AF, Berk M. Major depressive disorder. Nature Reviews Disease Primers. 2023;9(1):44.
[11]. 11.Moritz S, Nestoriuc Y, Rief W, Klein JP, Jelinek L, Peth J. It can’t hurt, right? Adverse effects of psychotherapy in patients with depression. European Archives of Psychiatry and Clinical Neuroscience. 2019;269:577–86.
[12]. 12.Yager J, Kay J. Money matters in psychiatric assessment, case formulation, treatment planning, and ongoing psychotherapy: clinical psychoeconomics. The Journal of Nervous and Mental Disease. 2022;210(11):811–7.
[13]. 13.Huibers MJH, Lorenzo-luaces L, Cuijpers P, Kazantzis N. On the road to personalized psychotherapy: A research agenda based on cognitive behavior therapy for depression. Frontiers in Psychiatry. 2021;11:607508.
[14]. 14.Ladmanová M, Řiháček T, Timulak L, Jonášová K, Kubantová B, Mikoška P, Polakovská L, Elliott R. Client-identified outcomes of individual psychotherapy: a qualitative meta-analysis. The Lancet Psychiatry. 2025;12(1):18–31.
[15]. 15.Lane RD, Subic-wrana C, Greenberg L, Yovel I. The role of enhanced emotional awareness in promoting change across psychotherapy modalities. Journal of Psychotherapy Integration. 2022;32(2):131.
[16]. 16.Markowitz JC, Milrod B, Heckman TG, Bergman M, Amsalem D. Psychotherapy at a distance. American Journal of Psychiatry. 2021;178(3):240–6.
[17]. 17.Huhn M, Tardy M, Spineli LM, Kissling W, Foerstl H. Efficacy of pharmacotherapy and psychotherapy for adult psychiatric disorders: A systematic overview of meta-analyses. JAMA psychiatry. 2014;71(6):706–15.
[18]. 18.Cosci F, Chouinard G. Acute and persistent withdrawal syndromes following discontinuation of psychotropic medications. Psychotherapy and psychosomatics. 2020;89(5):283–306.
[19]. 19.Pittenger C. Pharmacotherapeutic strategies and new targets in OCD. Accelerating Progress. 2021;331–84.
[20]. 20.Stein DJ, Shoptaw SJ, Vigo D V, Lund C, Cuijpers P, Bantjes J, Sartorius N, Maj M. Psychiatric diagnosis and treatment in the 21st century: paradigm shifts versus incremental integration. World Psychiatry. 2022;21(3):393–414.
[21]. 21.Guidi J, Fava GA. Sequential combination of pharmacotherapy and psychotherapy in major depressive disorder: a systematic review and meta-analysis. JAMA psychiatry. 2020;78(3):261–9.
[22]. 22.Dold M, Leucht S. Pharmacotherapy of treatment-resistant schizophrenia: a clinical perspective. BMJ Ment Health. 2014;17(2):33–7.
[23]. 23.Poloczek A, Szczerba J. The role of pharmacotherapy and psychotherapy in borderline personality disorder-a literature review. Journal of Education, Health and Sport. 2024;57:203–16.
[24]. 24.Donald C, Goff DC, Falkai P, Fleischhacker W, Girgis RR. The long-term effects of antipsychotic medication on clinical course in schizophrenia. American Journal of Psychiatry. 2017;174(9):840–9.
[25]. 25.Oliva V, Fico G, De Prisco M, Gonda X, Rosa AR, Vieta E. Bipolar disorders: an update on critical aspects. The Lancet Regional Health - Europe. 2025;48.
[26]. 26.Karataş Y, Khan Z, Khan FU. Adverse drug reactions with antidepressants drugs: aignificance of pharmacovigilance in depression pharmacotherapy. Arşiv Kaynak Tarama Dergisi. 2022;31(3):151–9.
[27]. 27.Patra I, Muda I, Ketut Acwin Dwijendra N, Najm MA, Hamoud Alshahrani S, Sajad Kadhim S, Hameed NM, Alnassar YS, Mohammed NM, Mustafa YF, Shojaeimotlagh V. A. Systematic Review and Meta-Analysis on Death Anxiety During COVID-19 Pandemic. OMEGA - Journal of Death and Dying. 2023; https://doi.org/10.1177/00302228221144791
[28]. 28.Abdollahi A, Prasad KD V., Abdelrasheed NSG, Alshahrani SH, Shoja SJ, Al-Awsi GRL, Estrada-Araoz EG, Singer N, Ramírez-Coronel AA, Mustafa YF, Iswanto AH. An investigation of relationships between body compassion, social physique anxiety and physical appearance perfectionism in young people from Iran. Journal of Eating Disorders. 2023;11(1):90.
[29]. 29.Volkow ND, Blanco C. Substance use disorders: a comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention. World Psychiatry. 2023;22(2):203–29.
[30]. 30.Morton E, Michalak EE, Levitt A, Levitan RD, Cheung A, Morehouse R, Ramasubbu R, Yatham LN, Tam EM, Lam RW. Quality of Life Impacts of Bright Light Treatment, Fluoxetine, and the Combination in Patients with Nonseasonal Major Depressive Disorder: A Randomized Clinical Trial. The Canadian Journal of Psychiatry. 2021;66(3):289–97.
[31]. 31.McCutcheon RA, Cowen P, Nour MM, Pillinger T. Psychotropic Taxonomies: Constructing a Therapeutic Framework for Psychiatry. Biological Psychiatry. 2024;
[32]. 32.Buch AM, Liston C. Dissecting diagnostic heterogeneity in depression by integrating neuroimaging and genetics. Neuropsychopharmacology. 2021;46(1):156–75.
[33]. 33.Waheed SA, Mustafa YF. Benzocoumarin backbone is a multifunctional and affordable scaffold with a vast scope of biological activities. Journal of Medicinal and Chemical Sciences. 2022;5(5):703–21.
[34]. 34.Nejres AM, Ali HK, Behnam SP, Mustafa YF. Potential effect of ammonium chloride on the optical physical properties of polyvinyl alcohol. Systematic Reviews in Pharmacy. 2020;11(6):726–32.
[35]. 35.Zeki NM, Mustafa YF. Natural linear coumarin-heterocyclic conjugates: A review of their roles in phytotherapy. Fitoterapia. 2024;175:105929.
[36]. 36.Mustafa YF, Zain Al-Abdeen SH, Khalil RR, Mohammed ET. Novel functionalized phenyl acetate derivatives of benzo [e]-bispyrone fused hybrids: Synthesis and biological activities. Results in Chemistry. 2023;5:100942.
[37]. 37.Jasim SF, Mustafa YF. Synthesis, ADME Study, and antimicrobial evaluation of novel naphthalene-based derivatives. Journal of Medicinal and Chemical Sciences. 2022;5(5):793–807.
[38]. 38.Roomi AB, Widjaja G, Savitri D, Jalil AT, Mustafa YF, Thangavelu L, Kazhibayeva G, Suksatan W, Chupradit S, Aravindhan S. SnO2:Au/Carbon Quantum Dots Nanocomposites: Synthesis, Characterization, and Antibacterial Activity. Journal of Nanostructures. 2021;11(3):514–23.
[39]. 39.Hachem K, Jasim SA, Al-Gazally ME, Riadi Y, Yasin G, Turki Jalil A, Abdulkadhm MM, Saleh MM, Fenjan MN, Mustafa YF, Dehno Khalaji A. Adsorption of Pb(II) and Cd(II) by magnetic chitosan-salicylaldehyde Schiff base: Synthesis, characterization, thermal study and antibacterial activity. Journal of the Chinese Chemical Society. 2022;69(3):512–21.
[40]. 40.Mustafa YF, Faisal AF, Alshaher MM, Hassan DA. Food-Derived Micronutrients as Alleviators of Age-Related Dysfunction: A Dive into Their Effects and Cellular Mechanisms. Indian Journal of Clinical Biochemistry. 2025; https://doi.org/10.1007/s12291-024-01297-7
[41]. 41.Bashir MK, Mustafa YF, Oglah MK. Antitumor, antioxidant, and antibacterial activities of glycosyl-conjugated compounds: A review. Systematic Reviews in Pharmacy. 2020;11(4):175–87.
[42]. 42.Mustafa YF, Mohammed ET, Khalil RR. Antioxidant and antitumor activities of methanolic extracts obtained from Red Delicious and Granny Smith apples’ seeds. Systematic Reviews in Pharmacy. 2020;11(4):570–6.
[43]. 43.Jesus RLC, Silva ILP, Araújo FA, Moraes RA, Silva LB, Brito DS, Lima GBC, Alves QL, Silva DF. 7-Hydroxycoumarin Induces Vasorelaxation in Animals with Essential Hypertension: Focus on Potassium Channels and Intracellular Ca2+ Mobilization. Molecules. 2022;27(21):7324.
[44]. 44.Kasim SM, Abdulaziz NT, Jasim MH, Mustafa YF. Resveratrol in cancer chemotherapy: Is it a preventer, protector, or fighter? Eurasian Chemical Communications. 2023;5(7):576–87.
[45]. 45.Waheed SA, Mustafa YF. The in vitro effects of new albocarbon-based coumarins on blood glucose-controlling enzymes. Journal of Medicinal and Chemical Sciences. 2022;5(6):954–67.
[46]. 46.Mustafa YF. Harmful Free Radicals in Aging: A Narrative Review of Their Detrimental Effects on Health. Indian Journal of Clinical Biochemistry. 2024;39(2):154–67.
[47]. 47.Abdulaziz NT, Mustafa YF. The Effect of Heat Variable on the Chemical Composition and Bioactivities of a Citrullus lanatus Seed Aqueous Extracts. Journal of Medicinal and Chemical Sciences. 2022;5(7):1166–76.
[48]. 48.Al-Shakarchi W, Abdulaziz NT, Mustafa YF. A review of the chemical, pharmacokinetic, and pharmacological aspects of quercetin. Eurasian Chemical Communications. 2022;4(7):645–56.
[49]. 49.Wang QH, Qin SW, Jiang JG. Improvement effects of esculetin on the formation and development of atherosclerosis. Biomedicine & Pharmacotherapy. 2022;150:113001.
[50]. 50.Ahmed BA, Mustafa YF, Ibrahim BY. Isolation and characterization of furanocoumarins from Golden Delicious apple seeds. J Med Chem Sci. 2022;5:537–45.
[51]. 51.Ban AA, Ibrahim BY, Mustafa YF. The Protective Role of Natural Coumarins Derivatives and Anpro Supplement Against Aflatoxin B1 Pollution in the Quails Coturnix Japonica Diet. Mesopotamia Journal of Agriculture. 2023;51(1):1–13.
[52]. 52.Ogawa H, Souri M, Kanouchi K, Osaki T, Ohkubo R, Kawanishi T, Wakai S, Morikane K, Ichinose A. A high titer of acquired factor V inhibitor in a hemodialysis patient who developed arterial thrombosis. International Journal of Hematology. 2019;109(2):214–20.
[53]. 53.Jibroo RN, Mustafa YF. Linearly ring-fused coumarins: A review of their cancer-fighting attributes. Results in Chemistry. 2024;8:101611.
[54]. 54.Mahmood AT, Kamal IK, Mustafa YF. Coumarin Backbone as a Door-Opening Key for Investigating Chloroxylenol as Oral Antimicrobial Agents: an In Vitro–In Silico Study. Russian Journal of Bioorganic Chemistry. 2024;50(6):2252–68.
[55]. 55.Mustafa YF, Mohammed NA alwahab. A promising oral 5-fluorouracil prodrug for lung tumor: Synthesis, characterization and release. Biochemical and Cellular Archives. 2021;21(Supp 1):1991–9.
[56]. 56.Mustafa YF. Chemotherapeutic applications of folate prodrugs: A review. NeuroQuantology. 2021;19(8):99–112.
[57]. 57.Bashir MK, Mustafa YF, Oglah MK. Synthesis and antitumor activity of new multifunctional coumarins. Periodico Tche Quimica. 2020;17(36):871–83.
[58]. 58.Mohammed ET, Khalil RR, Mustafa YF. Phytochemical Analysis and Antimicrobial Evaluation of Quince Seeds’ Extracts. Journal of Medicinal and Chemical Sciences. 2022;5(6):968–79.
[59]. 59.Jebir RM, Mustafa YF. Natural products catalog of allsweet watermelon seeds and evaluation of their novel coumarins as antimicrobial candidates. Journal of Medicinal and Chemical Sciences. 2022;5(5):831–47.
[60]. 60.Jebir MR, Mustafa YF. Kidney stones: natural remedies and lifestyle modifications to alleviate their burden. International Urology and Nephrology. 2024;56(3):1025–33.
[61]. 61.Mustafa YF, Ismael RN, Jebir RM. Natural coumarins from two cultivars of watermelon seeds as biosafe anticancer agents, an algorithm for their isolation and evaluation. Journal of Molecular Structure. 2024;1295(P1):136644.
[62]. 62.Abdulaziz NT, Mustafa YF. Antibacterial and Antitumor Potentials of Some Novel Coumarins. International Journal of Drug Delivery Technology. 2022;12(1):239–47.
[63]. 63.Ismael RN, Mustafa YF, Al-Qazaz HK. Cancer-curative potential of novel coumarins from watermelon princess: A scenario of their isolation and activity. Eurasian Chemical Communications. 2022;4(7):657–72.
[64]. 64.Mustafa YF. Nutraceutical-based telomerase inhibitors: Renewed hope for cancer therapy. Phytomedicine Plus. 2024;4(2):100537.
[65]. 65.Li Y, Wang GQ, Li Y Bin. Therapeutic potential of natural coumarins in autoimmune diseases with underlying mechanisms. Frontiers in Immunology. 2024;15:1–15.
[66]. 66.Alshaher MM, Mustafa YF. Synthesis of triclosan-derived coumarins as potent, biocompatible, broad-spectrum antimicrobial agents. Applied Chemical Engineering. 2024;7(4):5579.
[67]. 67.Rohmah MK, Salahdin OD, Gupta R, Muzammil K, Qasim MT, Al-qaim ZH, Abbas NF, Jawad MA, Yasin G, Mustafa YF, Heidary A, Abarghouei S. Modulatory role of dietary curcumin and resveratrol on growth performance, serum immunity responses, mucus enzymes activity, antioxidant capacity and serum and mucus biochemicals in the common carp, Cyprinus carpio exposed to abamectin. Fish and Shellfish Immunology. 2022;129:221–30.
[68]. 68.Mustafa YF. Coumarins from carcinogenic phenol: synthesis, characterization, in silico, biosafety, anticancer, antioxidant, and anti-inflammatory assessments. Chemical Papers. 2024;78:493–504.
[69]. 69.Hjazi A, Ghaffar E, Asghar W, Alauldeen Khalaf H, Ikram Ullah M, Mireya Romero-Parra R, Hussien BM, Abdulally Abdulhussien alazbjee A, Singh Bisht Y, Fakri Mustafa Y, Reza Hosseini-Fard S. CDKN2B-AS1 as a novel therapeutic target in cancer: Mechanism and clinical perspective. Biochemical Pharmacology. 2023;213:115627.
[70]. 70.Al Abdeen SHZ, Mustafa YF, Mutlag SH. Synthesis and biomedical activities of novel multifunctional benzodipyrone-based derivatives. Eurasian Chemical Communications. 2022;4(10):938–49.
[71]. 71.Yeom JW, Cho CH. Herbal and Natural Supplements for Improving Sleep: A Literature Review. Psychiatry Investigation. 2024;21(8):810–21.
[72]. 72.Al Abdeen SHZ, Mustafa YF, Mutlag SH. Synthesis of disubstituted anisolodipyronederived ester compounds: The search for new bioactive candidates. Eurasian Chemical Communications. 2022;4(11):1171–83.
[73]. 73.Mustafa YF, Bashir MK, Oglah MK. Synthesis, antioxidant and antitumor activities of new coumarins grafted to 5-fluorouracil. Caspian Journal of Environmental Sciences. 2022;20(2):359–65.
[74]. 74.Zhu Z, Feng X, Wang H, Fan J, Zhang C, Song G, Tang L. Design, synthesis and biological activity of coumarin-chalcone hybrid derivatives as phosphodiesterase type Ⅱ (PDE2) inhibitors. Tetrahedron. 2023;149:133733.
[75]. 75.Budi HS, Younus LA, Lafta MH, Parveen S, Mohammad HJ, Al-qaim ZH, Jawad MA, Parra RMR, Mustafa YF, Alhachami FR, Karampoor S, Mirzaei R. The role of miR-128 in cancer development, prevention, drug resistance, and immunotherapy. Frontiers in Oncology. 2023;12:1067974.
[76]. 76.Suksatan W, Chupradit S, Valerievich Yumashev A, Ravali S, Nader Shalaby M, Fakri Mustafa Y, Kurochkin A, Siahmansouri H. Immunotherapy of multisystem inflammatory syndrome in children (MIS-C) following COVID-19 through mesenchymal stem cells. International Immunopharmacology. 2021;101:108217.
[77]. 77.Baek SC, Kang MG, Park JE, Lee JP, Lee H, Ryu HW, Park CM, Park D, Cho ML, Oh SR, Kim H. Osthenol, a prenylated coumarin, as a monoamine oxidase A inhibitor with high selectivity. Bioorganic & Medicinal Chemistry Letters. 2019;29(6):839–43.
[78]. 78.Mahmood AAJ, Mustafa YF, Abdulstaar M. New coumarinic azo-derivatives of metoclopramide and diphenhydramine: Synthesis and in vitro testing for cholinesterase inhibitory effect and protection ability against chlorpyrifos. International Medical Journal Malaysia. 2014;13(1):3–12.
[79]. 79.Mustafa YF, Abdulaziz NT. Biological potentials of hymecromone-based derivatives: A systematic review. Systematic Reviews in Pharmacy. 2020;11(11):438–52.
[80]. 80.Patil SA, Kandathil V, Sobha A, Somappa SB, Feldman MR, Bugarin A, Patil SA. Comprehensive Review on Medicinal Applications of Coumarin-Derived Imine–Metal Complexes. Molecules. 2022;27(16):5220.
[81]. 81.Jebir RM, Mustafa YF. Watermelon Allsweet: A promising natural source of bioactive products. Journal of Medicinal and Chemical Sciences. 2022;5(5):652–66.
[82]. 82.Jasim SF, Mustafa YF. A Review of Classical and Advanced Methodologies for Benzocoumarin Synthesis. Journal of Medicinal and Chemical Sciences. 2022;5(5):676–94.
[83]. 83.Mustafa YF. Coumarins derived from natural methoxystilbene as oxidative stress-related disease alleviators: Synthesis and in vitro-in silico study. Journal of Molecular Structure. 2024;1302:137471.
[84]. 84.Jasim SF, Mustafa YF. Synthesis and Antidiabetic Assessment of New Coumarin-Disubstituted Benzene Conjugates: An In Silico-In Virto Study. Journal of Medicinal and Chemical Sciences. 2022;5(6):887–99.
[85]. 85.Mustafa YF, Bashir MK, Oglah MK, Khalil RR, Mohammed ET. Bioactivity of some natural and semisynthetic coumarin derived compounds. NeuroQuantology. 2021;19(6):129–38.
[86]. 86.Prottay AAS, Emamuzzaman, Ripu TR, Sarwar MN, Rahman T, Ahmmed MS, Bappi MH, Emon M, Ansari SA, Coutinho HDM, Islam MT. Anxiogenic-like effects of coumarin, possibly through the GABAkine interaction pathway: Animal studies with in silico approaches. Behavioural Brain Research. 2025;480:115392.
[87]. 87.Kawashima Y, Yamada M, Furuie H, Kuniishi H, Akagi K, Kawashima T, Noda T, Yamada M. Effects of riluzole on psychiatric disorders with anxiety or fear as primary symptoms: A systematic review. Neuropsychopharmacology Reports. 2023;43(3):320–7.
[88]. 88.Jebir RM, Mustafa YF. Novel coumarins isolated from the seeds of Citrullus lanatus as potential antimicrobial agents. Eurasian Chemical Communications. 2022;4(8):692–708.
[89]. 89.Ostrowska K. Coumarin-piperazine derivatives as biologically active compounds. Saudi Pharmaceutical Journal. 2020;28(2):220–32.
[90]. 90.Sang M, Liu Q, Li D, Dang J, Lu C, Liu C, Wu Q. Heat Stress and Microbial Stress Induced Defensive Phenol Accumulation in Medicinal Plant Sparganium stoloniferum. International Journal of Molecular Sciences. 2024;25(12):6379.
[91]. 91.Chamboko CR, Veldman W, Tata RB, Schoeberl B, Tastan Bishop Ö. Human Cytochrome P450 1, 2, 3 Families as Pharmacogenes with Emphases on Their Antimalarial and Antituberculosis Drugs and Prevalent African Alleles. International Journal of Molecular Sciences. 2023;24(4):3383.
[92]. 92.Mustafa YF. Synthesis of 7,8-dihydroxy-4-phenylbenzo[g]coumarins as potential multitarget anti-skin-aging candidates. Journal of Molecular Structure. 2025;1321:139806.
[93]. 93.Mustafa YF. Synthesis, in silico analysis, and biomedical effects of coumarins derived from resveratrol. Phytomedicine Plus. 2024;3(4):100501.
[94]. 94.Mustafa YF. Combretastatin A4-based coumarins: synthesis, anticancer, oxidative stress-relieving, anti-inflammatory, biosafety, and in silico analysis. Chemical Papers. 2024;78:3705–3720.
[95]. 95.Nimgampalle M, Chakravarthy H, Sharma S, Shree S, Bhat AR, Pradeepkiran JA, Devanathan V. Neurotransmitter systems in the etiology of major neurological disorders: Emerging insights and therapeutic implications. Ageing Research Reviews. 2023;89:101994.
[96]. 96.Cutler AJ, Mattingly GW, Maletic V. Understanding the mechanism of action and clinical effects of neuroactive steroids and GABAergic compounds in major depressive disorder. Translational Psychiatry. 2023;13(1):228.
[97]. 97.van Elk M, Yaden DB. Pharmacological, neural, and psychological mechanisms underlying psychedelics: A critical review. Neuroscience & Biobehavioral Reviews. 2022;140:104793.
[98]. 98.Edinoff AN, Akuly HA, Hanna TA, Ochoa CO, Patti SJ, Ghaffar YA, Kaye AD, Viswanath O, Urits I, Boyer AG, Cornett EM, Kaye AM. Selective Serotonin Reuptake Inhibitors and Adverse Effects: A Narrative Review. Neurology International. 2021;13(3):387–401.
[99]. 99.Mustafa YF, Bashir MK, Oglah MK. Influence of albocarbon-cyclic hybridization on biomedical activities: A review. Journal of Medicinal and Chemical Sciences. 2022;5(4):518–35.
[100]. 100.Tsivileva OM, Koftin O V, Evseeva N V. Coumarins as fungal metabolites with potential medicinal properties. Antibiotics. 2022;11(9):1156.
[101]. 101.Lois Adetunji T, Olisah C, Olatunde A, Tijjani H, Mubarak MS, Rauf A, Oladapo Aremu A. Global research landscape on two coumarin derivatives: A scientometric study of trends and innovations from 1990 to 2022. Arabian Journal of Chemistry. 2024;17(2):105494.
[102]. 102.Zeki NM, Mustafa YF. Coumarin hybrids for targeted therapies: A promising approach for potential drug candidates. Phytochemistry Letters. 2024;60:117–33.
[103]. 103.Mustafa YF. Biocompatible chlorocoumarins from harmful chlorophenols, their synthesis and biomedicinal evaluation. Journal of Molecular Structure. 2024;1309:138193.
[104]. 104.Angarita GA, Emadi N, Hodges S, Morgan PT. Sleep abnormalities associated with alcohol, cannabis, cocaine, and opiate use: a comprehensive review. Addiction Science & Clinical Practice. 2016;11(1):9.
[105]. 105.Banala S, Jin XT, Dilan TL, Sheu SH, Clapham DE, Drenan RM, Lavis LD. Elucidating and Optimizing the Photochemical Mechanism of Coumarin-Caged Tertiary Amines. Journal of the American Chemical Society. 2024;146(30):20627–35.
[106]. 106.Lin SH, Lee LT, Yang YK. Serotonin and Mental Disorders: A Concise Review on Molecular Neuroimaging Evidence. Clinical Psychopharmacology and Neuroscience. 2014;12(3):196–202.
[107]. 107.Ranjbar-Slamloo Y, Fazlali Z. Dopamine and Noradrenaline in the Brain; Overlapping or Dissociate Functions? Frontiers in Molecular Neuroscience. 2020;12:334.
[108]. 108.Kurach Ł, Kulczycka-mamona S, Kowalczyk J, Skalicka-wo K, Boguszewska-czubara A, El Sayed N, Osmani M, Iwaniak K, Budzyńska B. Mechanisms of the procognitive effects of xanthotoxin and umbelliferone on LPS-induced amnesia in mice. International Journal of Molecular Sciences. 2021;22(4):1779.
[109]. 109.Kaur P, Rangra NK. Recent Advancements and SAR Studies of Synthetic Coumarins as MAO-B Inhibitors: An Updated Review. Mini-Reviews in Medicinal Chemistry. 2024;24(20):1834–46.
[110]. 110.D’Aniello E, Paganos P, Anishchenko E, D’Aniello S, Arnone MI. Comparative Neurobiology of Biogenic Amines in Animal Models in Deuterostomes. Frontiers in Ecology and Evolution. 2020;8:587036.
[111]. 111.Widelski J, Kasica N, Maciąg M, Luca SV, Budzyńska B, Fondai D, Podlasz P, Skalicka-Woźniak K. Simple Coumarins from Peucedanum luxurians Fruits: Evaluation of Anxiolytic Activity and Influence on Gene Expression Related to Anxiety in Zebrafish Model. International Journal of Molecular Sciences. 2023;24(10):8693.
[112]. 112.Younes AH, Mustafa YF. Plant-Derived Coumarins: A Narrative Review Of Their Structural And Biomedical Diversity. Chemistry & Biodiversity. 2024;21(6):e202400344.
[113]. 113.Zeki NM, Mustafa YF. Coumarin hybrids: a sighting of their roles in drug targeting. Chemical Papers. 2024;78:5753–5772.
[114]. 114.Stefanachi A, Leonetti F, Pisani L, Catto M, Carotti A. Coumarin: A Natural, Privileged and Versatile Scaffold for Bioactive Compounds. Molecules. 2018;23(2):250.
[115]. 115.Price RB, Duman R. Neuroplasticity in cognitive and psychological mechanisms of depression: an integrative model. Molecular Psychiatry. 2020;25(3):530–43.
[116]. 116.Flórez-Vargas O, Brass A, Karystianis G, Bramhall M, Stevens R, Cruickshank S, Nenadic G. Bias in the reporting of sex and age in biomedical research on mouse models. eLife. 2016;5:e13615.
[117]. 117.Schwarting RKW, Wöhr M, Engler H, Sungur AÖ, Schedlowski M. Behaviorally conditioned effects of psychoactive drugs in experimental animals: What we have learned from nearly a century of research and what remains to be learned. Neuroscience & Biobehavioral Reviews. 2024;162:105721.
[118]. 118.Madbouly H, El-Shahat KH, Abdelnaby EA, El-Sherbiny HR, Fathi M. Determination of the impacts of supplemental dietary curcumin on post-partum uterine involution using pulsed-wave doppler ultrasonography in Zaraibi goat. BMC Veterinary Research. 2024;20(1):316.
[119]. 119.Nahrevanian H, Najafzadeh M, Hajihosseini R, Nazem H, Farahmand M, Zamani Z. Anti-leishmanial Effects of Trinitroglycerin in BALB/C Mice Infected with Leishmania major via Nitric Oxide Pathway. The Korean Journal of Parasitology. 2009;47(2):109.
[120]. 120.Mustafa YF. Effects of heat variables on the starch content of cooked white rice: Searching for diabetes-friendly food. Bioactive Carbohydrates and Dietary Fibre. 2024;31:100395.
[121]. 121.Bellavite P. Neuroprotective Potentials of Flavonoids: Experimental Studies and Mechanisms of Action. Antioxidants. 2023;12(2):280.
[122]. 122.Younes AH, Mustafa YF. Unveiling the Biomedical Applications of Novel Coumarins Isolated From Capsicum Annuum L. Seeds by a Multivariate Extraction Technique. Chemistry and Biodiversity. 2024;21(6):e202400581.
[123]. 123.Mustafa YF. 3-mercaptocoumarins as potential bioactive candidates: From novel synthesis to comparative analysis. Journal of Molecular Structure. 2025;1320:139657.
[124]. 124.Porter GA, O’Connor JC. Brain-derived neurotrophic factor and inflammation in depression: Pathogenic partners in crime? World Journal of Psychiatry. 2022;12(1):77–97.
[125]. 125.Lachowicz-Radulska J, Widelski J, Nowaczyński F, Serefko A, Sobczyński J, Ludwiczuk A, Kasica N, Szopa A. Zebrafish as a Suitable Model for Utilizing the Bioactivity of Coumarins and Coumarin-Based Compounds. International Journal of Molecular Sciences. 2025;26(4):1444.
[126]. 126.Zeki NM, Mustafa YF. Synthesis of Novel Dioxathiole-6,7-coumarin Hybrids As Cytosafe-Multifunctional Applicants: An In Vitro—In Silico Study. Russian Journal of Bioorganic Chemistry. 2024;50(5):2076–91.
[127]. 127.Zeki NM, Mustafa YF. 6,7-Coumarin-heterocyclic hybrids: A comprehensive review of their natural sources, synthetic approaches, and bioactivity. Journal of Molecular Structure. 2024;1303:137601.
[128]. 128.Orioli R, Belluti F, Gobbi S, Rampa A, Bisi A. Naturally Inspired Coumarin Derivatives in Alzheimer’s Disease Drug Discovery: Latest Advances and Current Challenges. Molecules. 2024;29(15):3514.
[129]. 129.Khalil HE, Abdelwahab MF, Ibrahim HIM, AlYahya KA, Altaweel AA, Alasoom AJ, Burshed HA, Alshawush MM, Waz S. Cichoriin, a Biocoumarin, Mitigates Oxidative Stress and Associated Adverse Dysfunctions on High-Fat Diet-Induced Obesity in Rats. Life. 2022;12(11):1731.
[130]. 130.Kenda M, Kočevar Glavač N, Nagy M, Sollner Dolenc M. Medicinal Plants Used for Anxiety, Depression, or Stress Treatment: An Update. Molecules. 2022;27(18):6021.
[131]. 131.Olsen RW, Liang J. Role of GABAA receptors in alcohol use disorders suggested by chronic intermittent ethanol (CIE) rodent model. Molecular Brain. 2017;10(1):45.
[132]. 132.Ríos JL, Schinella GR, Moragrega I. Phenolics as GABAA Receptor Ligands: An Updated Review. Molecules. 2022;27(6):1770.
[133]. 133.Lopresti AL, Smith SJ, Metse AP, Drummond PD. A randomized, double-blind, placebo-controlled trial investigating the effects of an Ocimum tenuiflorum (Holy Basil) extract (HolixerTM) on stress, mood, and sleep in adults experiencing stress. Frontiers in Nutrition. 2022;9:965130.
[134]. 134.Chaachouay N, Zidane L. Plant-Derived Natural Products: A Source for Drug Discovery and Development. Drugs and Drug Candidates. 2024;3(1):184–207.
[135]. 135.Villas-Boas GR, Lavorato SN, Paes MM, de Carvalho PMG, Rescia VC, Cunha MS, de Magalhães-Filho MF, Ponsoni LF, de Carvalho AAV, de Lacerda RB, da S. Leite L, da S. Tavares-Henriques M, Lopes LAF, Oliveira LGR, Silva-Filho SE, da Silveira APS, Cuman RKN, de S. Silva-Comar FM, et al. Modulation of the Serotonergic Receptosome in the Treatment of Anxiety and Depression: A Narrative Review of the Experimental Evidence. Pharmaceuticals. 2021;14(2):148.
[136]. 136.Lee STH. Inflammation, depression, and anxiety disorder: A population-based study examining the association between Interleukin-6 and the experiencing of depressive and anxiety symptoms. Psychiatry Research. 2020;285:112809.
[137]. 137.Younes AH, Mustafa YF. Novel coumarins from green sweet bell pepper seeds: Their isolation, characterization, oxidative stress-mitigating, anticancer, anti-inflammatory, and antidiabetic properties. Journal of Molecular Structure. 2024;1312:138629.
[138]. 138.Jibroo RN, Mustafa YF, Al-Shakarchi W. Synthesis and evaluation of linearly fused thiadiazolocoumarins as prospects with broad-spectrum bioactivity. Results in Chemistry. 2024;7:101494.
[139]. 139.Mustafa YF. Synthesis of novel 6-aminocoumarin derivatives as potential –biocompatible antimicrobial and anticancer agents. Journal of Molecular Structure. 2025;1320:139658.
[140]. 140.Mustafa YF, Hassan DA, Faisal AF, Alshaher MM. Synthesis of novel skipped diene-3-halocoumarin conjugates as potent anticancer and antibacterial biocompatible agents. Results in Chemistry. 2024;11:101846.
[141]. 141.Kamal IK, Mahmood AT, Mustafa YF. Synthesis of Eugenol-Derived Coumarins as Broad-Spectrum Biosafe Antimicrobial Agents. Russian Journal of Bioorganic Chemistry. 2024;50(6):2240–51.
[142]. 142.Mustafa YF. Coumarins from toxic phenol: An algorithm of their synthesis and assessment as biosafe, wide-spectrum, potent antimicrobial prospects. Applied Chemical Engineering. 2024;7(3):5527.
[143]. 143.P S, Vellapandian C. Hypothalamic-Pituitary-Adrenal (HPA) Axis: Unveiling the Potential Mechanisms Involved in Stress-Induced Alzheimer’s Disease and Depression. Cureus. 2024;16(8):e67595.
[144]. 144.Khalifa NE, Noreldin AE, Khafaga AF, El-Beskawy M, Khalifa E, El-Far AH, Fayed AHA, Zakaria A. Chia seeds oil ameliorate chronic immobilization stress-induced neurodisturbance in rat brains via activation of the antioxidant/anti-inflammatory/antiapoptotic signaling pathways. Scientific Reports. 2023;13(1):22409.
[145]. 145.Abdulaziz NT, Mohammed ET, Khalil RR, Mustafa YF. Unrevealing the total phenols, total flavonoids, antioxidant, anti-inflammatory, and cytotoxic effects of Garden Cress seed ethanolic extracts. Review of Clinical Pharmacology and Pharmacokinetics - International Edition. 2024;38(2):187–96.
[146]. 146.Abdulaziz NT, Al-bazzaz FY, Mustafa YF. Natural products for attenuating Alzheimer’s disease: A narrative review. Eurasian Chemical Communications. 2023;5(4):358–70.
[147]. 147.Raheem Lateef Al-Awsi G, Hadi Lafta M, Hashim Kzar H, Samieva G, Alsaikhan F, Ahmad I, Mahmood Saleh M, Alamin Altoum A, Aravindhan S, Fakri Mustafa Y, Mahmoudi R, Mohammadi A. PCSK9 pathway-noncoding RNAs crosstalk: Emerging opportunities for novel therapeutic approaches in inflammatory atherosclerosis. International Immunopharmacology. 2022;113:109318.
[148]. 148.Soltani A, Chugaeva UY, Ramadan MF, Saleh EAM, Al-Hasnawi SS, Romero-Parra RM, Alsaalamy A, Mustafa YF, Zamanian MY, Golmohammadi M. A narrative review of the effects of dexamethasone on traumatic brain injury in clinical and animal studies: focusing on inflammation. Inflammopharmacology. 2023;31(6):2955–71.
[149]. 149.Golmohammadi M, Ivraghi MS, Hasan EK, Huldani H, Zamanian MY, Rouzbahani S, Mustafa YF, Al-Hasnawi SS, Alazbjee AAA, Khalajimoqim F, Khalaj F. Protective effects of pioglitazone in renal ischemia–reperfusion injury (RIRI): focus on oxidative stress and inflammation. Clinical and Experimental Nephrology. 2024;28(10):955–68.
[150]. 150.Suliman M, Al-Hawary SIS, Al-dolaimy F, Hjazi A, Almalki SG, Alkhafaji AT, Alawadi AH, Alsaalamy A, Bijlwan S, Mustafa YF. Inflammatory diseases: Function of LncRNAs in their emergence and the role of mesenchymal stem cell secretome in their treatment. Pathology - Research and Practice. 2023;249:154758.
[151]. 151.Jibroo RN, Mustafa YF, Al-Shakarchi W. Heterocycles fused on a 6,7-coumarin framework: an in-depth review of their structural and pharmacological diversity. Chemical Papers. 2024;78:7239–7311.
[152]. 152.Zeki NM, Mustafa YF. Novel heterocyclic coumarin annulates: synthesis and figuring their roles in biomedicine, bench-to-bedside investigation. Chemical Papers. 2024;78:4935–51.
[153]. 153.Mustafa YF. 4-Chloroskimmetine-based derivatives as potential anticancer and antibacterial prospects: Their synthesis and in vitro inspections. Results in Chemistry. 2024;7:101511.
[154]. 154.Shahwan M, Prasad P, Yadav DK, Altwaijry N, Khan MS, Shamsi A. Identification of high-affinity Monoamine oxidase B inhibitors for depression and Parkinson’s disease treatment: bioinformatic approach of drug repurposing. Frontiers in Pharmacology. 2024;15:1422080.
[155]. 155.Zamanian MY, Parra RMR, Soltani A, Kujawska M, Mustafa YF, Raheem G, Al-Awsi L, Lafta HA, Taheri N, Heidari M, Golmohammadi M, Bazmandegan G. Targeting Nrf2 signaling pathway and oxidative stress by resveratrol for Parkinson’s disease: an overview and update on new developments. Molecular Biology Reports. 2023;50:5455–5464.
[156]. 156.Zagaja M, Zagaja A, Szala-rycaj J, Szewczyk A, Lemieszek MK, Raszewski G, Andres-mach M. Influence of umbelliferone on the anticonvulsant and neuroprotective activity of selected antiepileptic drugs: an in vivo and in vitro study. International Journal of Molecular Sciences. 2022;23(7):3492.
[157]. 157.Pannu A, Goyal RK, Sharma K. The potential role of herbal plants in the management of depression: pre-clinical and clinical evidence. Current Nutraceuticals. 2024;
[158]. 158.Ju S, Tan Y, Wang Q, Zhou L, Wang K, Wen C, Wang M. Antioxidant and anti‑inflammatory effects of esculin and esculetin. Experimental and Therapeutic Medicine. 2024;27(6):1–14.
[159]. 159.Kim J hoon, Marton J, Ametamey SM, Cumming P. A Review of molecular imaging of glutamate receptors. Molecules. 2020;25(20):4749.
[160]. 160.Yan L, Jin Y, Pan J, He X, Zhong S, Zhang R, Choi L. 7,8-Dihydroxycoumarin alleviates synaptic loss by activated PI3K-Akt-CREB-BDNF signaling in Alzheimer’s disease model mice. Journal of Agricultural and Food Chemistry. 2022;70(23):7130–8.
[161]. 161.Khushboo, Kumar A, Sharma B. Biomedical implications of plant-based principles as antidepressants: prospects for novel drug development. Mini reviews in medicinal chemistry. 2022;22(6):904–26.
[162]. 162.Di Stasi LC. Natural Coumarin Derivatives Activating Nrf2 Signaling Pathway as Lead Compounds for the Design and Synthesis of Intestinal Anti-Inflammatory Drugs. Pharmaceuticals. 2023;16(4):511.
[163]. 163.Wang X, Fu X, Luo X, Lai Y, Cai C, Liao Y, Dai Z, Fang S, Fang J. Network Proximity Analysis Deciphers the Pharmacological Mechanism of Osthole against D-Galactose Induced Cognitive Disorder in Rats. Molecules. 2024;29(1):21.
[164]. 164.Kowalczyk J, Nakos-Bimpos M, Polissidis A, Dalla C, Kokras N, Skalicka-wo K, Budzy B. Imperatorin influences depressive-like behaviors: a preclinical study on behavioral and neurochemical sex differences. Molecules. 2022;27(4):1179.
[165]. 165.Ren Y, Song X, Tan L, Guo C, Wang M, Liu H. A review of the pharmacological properties of psoralen. Frontiers in pharmacology. 2020;11:571535.
[166]. 166.Kowalczyk J, Kurach Ł, Boguszewska-czubara A, Kruk-słomka M, Kurzepa J, Skalicka-wo K, Ramirez MJ. Bergapten improves scopolamine-induced memory impairment in mice via cholinergic and antioxidative mechanisms. Frontiers in Neuroscience. 2020;14:730.
[167]. 167.Agarwal U, Pannu A, Tonk RK, Jaiswal P, Jain K. The potential of xanthotoxin in the treatment of cognitive disorders: current insights and future perspectives. Future Journal of Pharmaceutical Sciences. 2024;10(1):147.
[168]. 168.Bartnik M. Methoxyfuranocoumarins of Natural Origin–Updating Biological Activity Research and Searching for New Directions—A Review. Current Issues in Molecular Biology. 2024;46(1):856–83.
[169]. 169.Chaurasiya ND, Leon F, Muhammad I, Tekwani BL. Natural products inhibitors of monoamine oxidases—Potential new drug leads for neuroprotection, neurological disorders, and neuroblastoma. Molecules. 2022;27(13):4297.
[170]. 170.Wei Z, Wei N, Su L, Gao S. The molecular effects underlying the pharmacological activities of daphnetin. Frontiers in Pharmacology. 2024;15:1407010.
[171]. 171.Chang BY, Jung YS, Yoon CS, Oh JS, Hong JH, Kim YC, Kim SY. Fraxin prevents chemically induced hepatotoxicity by reducing oxidative stress. Molecules. 2017;22(4):587.
[172]. 172.Sun W, Yin Q, Wan H, Gao R, Xiong C, Xie C, Meng X, Mi Y, Wang X, Wang C, Chen W, Xie Z, Xue Z, Yao H, Sun P, Xie X, Hu Z, Nelson DR, et al. Characterization of the horse chestnut genome reveals the evolution of aescin and aesculin biosynthesis. Nature communications. 2023;14(1):6470.
[173]. 173.Rebas E, Rzajew J, Radzik T, Zylinska L. Neuroprotective polyphenols: a modulatory action on neurotransmitter pathways. Current neuropharmacology. 2020;18(5):431–45.
[174]. 174.Mirzavi F, Rajabian A, Hosseini H, Hosseini A. Herniarin ameliorates acrylamide-induced neurotoxicity in rat: involvement of neuro-inflammation and acetylcholinesterase. Natural Product Research. 2024;1–8.
[175]. 175.Zhang J, Li L, Jiang C, Xing C, Kim SH, Lu J. Anti-cancer and Other Bioactivities of Korean Angelica gigas Nakai (AGN) and Its Major Pyranocoumarin Compounds. Anti-Cancer Agents in Medicinal Chemistry. 2012;12(10):1239–54.
[176]. 176.Zeki NM, Mustafa YF. Synthesis and Pharmacological Profiles of 6,7-Dihydroxycoumarin and Its Derivatives: A Concise Review. Iraqi Journal of Pharmacy. 2023;20(Supplementary Issue 1):174–88.
[177]. 177.Mohamed FAM. A current summary of coumarin-based compounds and their therapeutic applications. Egyptian Journal of Chemistry. 2024;67(13):1417–37.
[178]. 178.Umarani S, Kumar KA, Ganesh K. Esculin’s antioxidant effect on lead acetate-induced neurotoxicity in the C57BL/6 mice’s hippocampus and cortex. International Journal of Life Sciences Biotechnology and Pharma Sciences. 2020;16(3):14–20.
[179]. 179.Karimi P, Ghahfarroki M, Lorigooini Z, Shahgholian M, Amini-Khoei H. Umbelliprenin via increase in the MECP2 and attenuation of oxidative stress mitigates the autistic-like behaviors in mouse model of maternal separation stress. Frontiers in Pharmacology. 2024;14:1300310.
[180]. 180.Bagheri SM, Allahtavakoli M, Moradi A. Acetylcholinesterase inhibitory activity of Ferula plants and their potential for treatment of Alzheimer’s disease. Journal of Complementary and Integrative Medicine,. 2024;21(4).
[181]. 181.Biso L, Carli M, Scarselli M, Longoni B. Overview of Novel Antipsychotic Drugs: State of the Art, New Mechanisms, and Clinical Aspects of Promising Compounds. Biomedicines. 2025;13(1):85.
[182]. 182.Mahmudiono T, Jasim SA, Karim YS, Bokov DO, Abdelbasset WK, Akhmedov KS, Yasin G, Thangavelu L, Mustafa YF, Shoukat S, Najm MAA, Amraei M. The effect of flaxseed oil consumtion on blood pressure among patients with metabolic syndrome and related disorders: A systematic review and meta-analysis of randomized clinical trials. Phytotherapy Research. 2022;36(10):3766–73.
[183]. 183.Alshahrani SH, Ramaiah P, Dheyab AS, Rudiansyah M, Qasim QA, Altalbawy FMA, Obaid RF, Almulla AF, Ramírez-Coronel AA, Gabr GA, Nasirin C, Mustafa YF, Amin Naghda A. The effect of watermelon supplementation on blood pressure: a meta-analysis of randomised clinical trials. Journal of Herbal Medicine. 2023;41:100726.
[184]. 184.Zeki NM, Mustafa YF. Annulated Heterocyclic[g]Coumarin Composites: Synthetic Approaches and Bioactive Profiling. Chemistry and Biodiversity. 2024;21(3):e202301855.
[185]. 185.Sharifi-Rad J, Cruz-Martins N, López-Jornet P, Lopez EPF, Harun N, Yeskaliyeva B, Beyatli A, Sytar O, Shaheen S, Sharopov F, Taheri Y, Docea AO, Calina D, Cho WC. Natural Coumarins: Exploring the Pharmacological Complexity and Underlying Molecular Mechanisms. Gil G, editor. Oxidative Medicine and Cellular Longevity. 2021;2021:6492346.
[186]. 186.Simeonova KB, Koleva AI, Petkova-Yankova NI, Zlatanova AMR, Lozanova V, Nikolova RD, Petkov P St. Elucidating the Mechanism of Coumarin Homodimerization Using 3-Acetylcoumarin Derivatives. Molecules. 2025;30(3):651.
[187]. 187.Saadati F, Modarresi Chahardehi A, Jamshidi N, Jamshidi N, Ghasemi D. Coumarin: A natural solution for alleviating inflammatory disorders. Current Research in Pharmacology and Drug Discovery. 2024;7:100202.
[188]. 188.Waheed SA, Mustafa YF. Synthesis and evaluation of new coumarins as antitumor and antioxidant applicants. Journal of Medicinal and Chemical Sciences. 2022;5(5):808–19.
[189]. 189.Saha B, Das A, Jangid K, Kumar A, Kumar V, Jaitak V. Identification of coumarin derivatives targeting acetylcholinesterase for Alzheimer’s disease by field-based 3D-QSAR, pharmacophore model-based virtual screening, molecular docking, MM/GBSA, ADME and MD Simulation study. Current Research in Structural Biology. 2024;7:100124.
[190]. 190.Olędzka AJ, Czerwińska ME. Role of Plant-Derived Compounds in the Molecular Pathways Related to Inflammation. International Journal of Molecular Sciences. 2023;24(5):4666.
[191]. 191.Mustafa YF, Abdulaziza NT, Jasim MH. 4-Methylumbelliferone and its derived compounds: A brief review of their cytotoxicity. Egyptian Journal of Chemistry. 2021;64(4):1807–16.
[192]. 192.Jasim SF, Mustafa YF. New fused-coumarin composites: Synthesis, anticancer and antioxidant potentials evaluation. Eurasian Chemical Communications. 2022;4(7):607–19.
[193]. 193.Ismael RN, Mustafa YF, Al-qazaz HK. Citrullus lanatus, a Potential Source of Medicinal Products : A Review. Journal of Medicinal and Chemical Sciences. 2022;5(4):607–18.
[194]. 194.Pruccoli L, Morroni F, Sita G, Hrelia P, Tarozzi A. Esculetin as a bifunctional antioxidant prevents and counteracts the oxidative stress and neuronal death induced by amyloid protein in sh-sy5y cells. Antioxidants. 2020;9(6):1–16.
[195]. 195.Zhang X, Ma W, Liu H, Liu Y, Zhang Y, He S, Ding X, Li B, Yan Y. Daphnetin protects neurons in an Alzheimer disease mouse model and normal rat neurons by inhibiting BACE1 activity and activating the Nrf2/HO-1 pathway. Journal of Neuropathology & Experimental Neurology. 2024;83(8):670–83.
[196]. 196.Sun M, Sun M, Zhang J. Osthole: an overview of its sources, biological activities, and modification development. Medicinal Chemistry Research. 2021;30(10):1767–94.
[197]. 197.Budzynska B, Boguszewska-Czubara A, Kruk-Slomka M, Skalicka-Wozniak K, Michalak A, Musik I, Biala G. Effects of imperatorin on scopolamine-induced cognitive impairment and oxidative stress in mice. Psychopharmacology. 2015;232(5):931–42.
[198]. 198.McCutcheon RA, Keefe RSE, McGuire PK. Cognitive impairment in schizophrenia: aetiology, pathophysiology, and treatment. Molecular Psychiatry. 2023;28(5):1902–18.
[199]. 199.Younes HA, Mustafa YF. Sweet Bell Pepper: A Focus on Its Nutritional Qualities and Illness-Alleviated Properties. Indian Journal of Clinical Biochemistry. 2024;39:459–69.
[200]. 200.Khalil RR, Mohammed ET, Mustafa YF. Various promising biological effects of Cranberry extract: A review. Clinical Schizophrenia and Related Psychoses. 2021;15(S6):1–9.
[201]. 201.Mustafa YF. Triple coumarin-based 5-fluorouracil prodrugs, their synthesis, characterization, and release kinetics. Journal of Molecular Structure. 2024;1301:137415.
[202]. 202.Zeki NM, Mustafa YF. Digital alchemy: Exploring the pharmacokinetic and toxicity profiles of selected coumarin-heterocycle hybrids. Results in Chemistry. 2024;10:101754.
[203]. 203.Mustafa YF, Oglah MK, Bashir MK. Conjugation of sinapic acid analogues with 5- Fluorouracil: Synthesis, preliminary cytotoxicity, and release study. Systematic Reviews in Pharmacy. 2020;11(3):482–9.
[204]. 204.Shelash Al‐Hawary SI, Abdalkareem Jasim S, M. Kadhim M, Jaafar Saadoon S, Ahmad I, Romero Parra RM, Hasan Hammoodi S, Abulkassim R, M. Hameed N, K. Alkhafaje W, Mustafa YF, Javed Ansari M. Curcumin in the treatment of liver cancer: From mechanisms of action to nanoformulations. Phytotherapy Research. 2023;37(4):1624–39.
[205]. 205.Efriza E, Alshahrani SH, Zekiy AO, Al-Awsi GRL, Sharma SK, Ramírez-Coronel AA, Shakeel N, Riadi Y, Aminov Z, Zabibah RS, Mustafa YF, Najafi ML. Exposure to polycyclic aromatic hydrocarbons and liver function: a systematic review of observational studies. Air Quality, Atmosphere & Health. 2023;16(5):1079–88.
[206]. 206.Pitaro M, Croce N, Gallo V, Arienzo A, Salvatore G, Antonini G. Coumarin-Induced Hepatotoxicity: A Narrative Review. Molecules. 2022;27(24):9063.
[207]. 207.Zuo HL, Huang HY, Lin YCD, Cai XX, Kong XJ, Luo DL, Zhou YH, Huang HD. Enzyme Activity of Natural Products on Cytochrome P450. Molecules. 2022;27(2):515.
[208]. 208.Hakkola J, Hukkanen J, Turpeinen M, Pelkonen O. Inhibition and induction of CYP enzymes in humans: an update. Archives of Toxicology. 2020;94(11):3671–722.
[209]. 209.Lu PH, Liao TH, Chen YH, Hsu YL, Kuo CY, Chan CC, Wang LK, Chern CY, Tsai FM. Coumarin Derivatives Inhibit ADP-Induced Platelet Activation and Aggregation. Molecules. 2022;27(13):4054.
[210]. 210.Kasperkiewicz K, Ponczek MB, Owczarek J, Guga P. Antagonists of vitamin K—popular coumarin drugs and new synthetic and natural coumarin derivatives. Molecules. 2020;25(1465):1–24.
[211]. 211.Mustafa YF, Mohammed ET, Khalil RR. Synthesis, characterization, and anticoagulant activity of new functionalized biscoumarins. Egyptian Journal of Chemistry. 2021;64(8):4461–8.
[212]. 212.Mishra PS, Kumar A, Kaur K, Jaitak V. Recent Developments in Coumarin Derivatives as Neuroprotective Agents. Current Medicinal Chemistry. 2024;31(35):5702–38.
[213]. 213.Al-Shakarchi W, Saber Y, Merkhan MM, Mustafa YF. Sub Chronic Toxicity Study of Coumacines. Pharmacognosy Journal. 2023;15(1):160–4.
[214]. 214.Al-Shakarchi W, Saber Y, Merkhan M, Mustafa YF. Acute toxicity of coumacines: An in vivo study. Georgian medical news. 2023;(338):126–31.
[215]. 215.Grosu (Dumitrescu) C, Jîjie AR, Manea HC, Moacă EA, Iftode A, Minda D, Chioibaş R, Dehelean CA, Vlad CS. New Insights Concerning Phytophotodermatitis Induced by Phototoxic Plants. Life. 2024;14(8):1019.
[216]. 216.Younis MA, Hamid OA, Dhaher R, Saber Y, Al-shakarchi W, Merkhan MM, Mustafa YF. Characterization of the renal safety profiles of coumacines. Pharmakeftiki. 2023;35(4):57–63.
[217]. 217.Banikazemi Z, Mirazimi SM, Dashti F, Mazandaranian MR, Akbari M, Morshedi K, Aslanbeigi F, Rashidian A, Chamanara M, Hamblin MR, Taghizadeh M, Mirzaei H. Coumarins and Gastrointestinal Cancer: A New Therapeutic Option? Frontiers in Oncology. 2021;11:752784.
[218]. 218.Mustafa YF. Emerging trends and future opportunities for coumarin-heterocycle conjugates as antibacterial agents. Results in Chemistry. 2023;6:101151.
[219]. 219.Waheed SA, Mustafa YF. Novel naphthalene-derived coumarin composites: synthesis, antibacterial, and antifungal activity assessments. Eurasian Chemical Communications. 2022;4(8):709–24.
[220]. 220.Mustafa YF. New Coumarin-Metronidazole Composites: Synthesis, Biocompatibility, and Anti-anaerobic Bacterial Activity. Russian Journal of Bioorganic Chemistry. 2024;50(1):201–10.
[221]. 221.Zeki MN, Mustafa YF. Synthesis and evaluation of novel ring-conjugated coumarins as biosafe broad-spectrum antimicrobial candidates. Journal of Molecular Structure. 2024;1309:138192.
[222]. 222.Lončar M, Jakovljević M, Šubarić D, Pavlić M, Služek VB, Cindrić I, Molnar M. Coumarins in food and methods of their determination. Foods. 2020;9(5):645.
[223]. 223.Hossam Abdelmonem B, Abdelaal NM, Anwer EKE, Rashwan AA, Hussein MA, Ahmed YF, Khashana R, Hanna MM, Abdelnaser A. Decoding the Role of CYP450 Enzymes in Metabolism and Disease: A Comprehensive Review. Biomedicines. 2024;12(7):1467.